N4 Pharma UK Ltd.
Quick facts
Marketed products
Phase 3 pipeline
- Sublingual sildenafil · Urology
Sublingual sildenafil works by increasing blood flow to the penis to treat erectile dysfunction.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about N4 Pharma UK Ltd.
What are N4 Pharma UK Ltd.'s marketed drugs?
Top marketed products include Oral sildenafil.
What is N4 Pharma UK Ltd.'s pipeline?
N4 Pharma UK Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Sublingual sildenafil.
Related
- Oral sildenafil
- Sector hub: All tracked pharma companies